Vyepti (Eptinezumab-jjmr) is a prescription drug approved by the FDA as a preventative treatment for migraines in adults. It is a type of monoclonal antibody called a calcitonin gene-related peptide (CGRP) antagonist, which works by blocking CGRP, a protein that can cause migraine headaches. Vyepti is administered by Show Full Answer
Vyepti (Eptinezumab-jjmr) is a prescription drug approved by the FDA as a preventative treatment for migraines in adults. It is a type of monoclonal antibody called a calcitonin gene-related peptide (CGRP) antagonist, which works by blocking CGRP, a protein that can cause migraine headaches. Vyepti is administered by intravenous (IV) infusion every three months.
Common side effects include:
- Scratchy throat
- Stuffy nose
- Allergic reactions, including skin changes like a rash
Some serious allergic reactions may occur, including swelling of the skin.
For more details, you can visit the following resources:
- [Vyepti — Lundbeck](https://www.vyepti.com)
- [Eptinezumab-jjmr Injection — Medline Plus](https://medlineplus.gov/druginfo/meds/a620022.html)
If you have any personal experiences or questions about Vyepti, it might be helpful to connect with others on platforms like MyMigraineTeam, where members share their stories and advice.
August 24, 2024
Join
Your Privacy Choices
